Citation Impact
Citing Papers
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair
2005
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?
2016
Genetic factors affecting drug disposition in Asian cancer patients
2015
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
2007 StandoutNobel
N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery
2005 Standout
VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation
2005
Polymorphisms in the VKORC1 gene are strongly associated with warfarin dosage requirements in patients receiving anticoagulation
2006
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
2010 StandoutNobel
Sarcopenia: a chronic complication of type 2 diabetes mellitus
2018 Standout
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
2014 Standout
Oral Anticoagulant Therapy
2012 Standout
Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarin
2006
Hypoxia-inducible factor 1-induced G protein-coupled receptor 35 expression is an early marker of progressive cardiac remodelling
2013
Pharmacological Management of Atrial Fibrillation following Cardiac Surgery
2005
Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants
2008
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
2008 Standout
Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction
2014
Concordance of functional in vitro data and epidemiological associations in complex disease genetics
2006
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Cancer-associated cachexia
2018 Standout
Metazoan MicroRNAs
2018 Standout
Hypoxia inducible factor 1 (HIF-1) and cardioprotection
2010
Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
2008
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
The Missing Diversity in Human Genetic Studies
2019 Standout
VKORC1: molecular target of coumarins
2007
Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review
2010
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
A genotyping method for VKORC1 1173C>T by Pyrosequencing®technology
2008 StandoutNobel
Hallmarks of Cellular Senescence
2018 Standout
Several-fold increase in risk of overanticoagulation by CYP2C9 mutations
2005
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice
2009
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
2016 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
The Hallmarks of Aging
2013 Standout
Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery
2003
Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy
2009
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans
2006
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
2006 StandoutNobel
CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese
2006
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
Oxygen homeostasis
2009 StandoutNobel
Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population
2005
Engineering Adolescence
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery
2002
Influence of CYP2C9 and VKORC1 on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–Americans
2008
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery
2013
Chemotherapy for advanced gastric cancer
2017 Standout
The influence of sequence variations in factor VII, γ-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement
2006
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Clinical, Agricultural, and Evolutionary Biology of Myostatin: A Comparative Review
2008
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update
2017
Mechano-Electrical Interaction Late After Fontan Operation
2004
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
CYP2C9*8 is Prevalent Among African–Americans: Implications for Pharmacogenetic Dosing
2009
Biomarkers of Coagulation, Inflammation, and Angiogenesis are Independently Associated with Preeclampsia
2012 StandoutNobel
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1α, is a direct and sufficient stimulus for brain-type natriuretic peptide induction
2007
Sarcopenia in heart failure: mechanisms and therapeutic strategies.
2016
A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) ina patient on warfarin therapy
2006
Works of Ming-Jen Lu being referenced
The role of P wave in prediction of atrial fibrillation after coronary artery surgery
1999
Myostatin expression in ventricular myocardium in a rat model of volume‐overload heart failure
2006
Hypoxic preconditioning protects rat hearts against ischemia–reperfusion injury via the arachidonate12-lipoxygenase/transient receptor potential vanilloid 1 pathway
2014
Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting
2000
A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity
2005
Carvedilol Modulates the Expression of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor in a Rat Model of Volume-Overload Heart Failure
2005